Search Results - "Hogdall, Estrid"

Fast processing of gynecologic cancer tissue in Danish Cancer Biobank makes them well-suited for biomarker studies by von Wowern, Frederik, Høgdall, Estrid

“…Gynecologic cancers remain a frequent and deadly diagnosis. Historically, treatment has focused on a "one size fits all" approach, but there is an urgent need…”
Get full text

MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer by James, Jaslin P, Riis, Lene Buhl, Malham, Mikkel, Høgdall, Estrid, Langholz, Ebbe, Nielsen, Boye S

“…Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC). These are chronic autoimmune diseases of unknown etiology affecting…”
Get full text

HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review by Karlsen, Nikoline S, Karlsen, Mona A, Høgdall, Claus K, Høgdall, Estrid V S

“…Human epididymis protein 4 (HE4) has received major attention as a potential tumor marker in epithelial ovarian cancer; however, evidence of significant…”
Get full text

DNA alterations in ovarian adult granulosa cell tumours: A scoping review protocol by Karstensen, Sven, Kaiser, Karsten, Moos, Caroline, Poulsen, Tim Svenstrup, Jochumsen, Kirsten, Høgdall, Claus, Lauszus, Finn, Høgdall, Estrid

“…Identifying and describing molecular alterations in tumors has become common with the development of high-throughput sequencing. However, DNA sequencing in…”
Get full text

The IGF-PAPP-A-Stanniocalcin Axis in Serum and Ascites Associates with Prognosis in Patients with Ovarian Cancer by Hjortebjerg, Rikke, Høgdall, Claus, Hansen, Kristian Horsman, Høgdall, Estrid, Frystyk, Jan

“…Pregnancy-associated plasma protein-A (PAPP-A) and PAPP-A2 modulate insulin-like growth factor (IGF) action and are inhibited by the stanniocalcins (STC1 and…”
Get full text

A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer — An international multicenter study in women with an ovarian mass by Karlsen, Mona A, Høgdall, Estrid V.S, Christensen, Ib J, Borgfeldt, Christer, Kalapotharakos, Grigorios, Zdrazilova-Dubska, Lenka, Chovanec, Josef, Lok, Christianne A.R, Stiekema, Anna, Mutz-Dehbalaie, Irene, Rosenthal, Adam N, Moore, Elizabeth K, Schodin, Beth A, Sumpaico, Walfrido W, Sundfeldt, Karin, Kristjansdottir, Björg, Zapardiel, Ignacio, Høgdall, Claus K

“…Abstract Aim To develop and validate a biomarker-based index to optimize referral and diagnosis of patients with suspected ovarian cancer. Furthermore, to…”
Get full text

Human Papillomavirus Genotyping and p16 Expression As Prognostic Factors for Patients With American Joint Committee on Cancer Stages I to III Carcinoma of the Anal Canal by SERUP-HANSEN, Eva, LINNEMANN, Dorte, SKOVRIDER-RUMINSKI, Wojciech, HØGDALL, Estrid, GEERTSEN, Poul Flemming, HAVSTEEN, Hanne

“…Carcinomas of the anal canal are strongly associated with the human papillomavirus (HPV). Expression of p16 is used as a surrogate marker of HPV infection. In…”
Get full text

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma by Reddy, Anupama, Zhang, Jenny, Davis, Nicholas S., Moffitt, Andrea B., Love, Cassandra L., Waldrop, Alexander, Leppa, Sirpa, Pasanen, Annika, Meriranta, Leo, Karjalainen-Lindsberg, Marja-Liisa, Nørgaard, Peter, Pedersen, Mette, Gang, Anne O., Høgdall, Estrid, Heavican, Tayla B., Lone, Waseem, Iqbal, Javeed, Qin, Qiu, Li, Guojie, Kim, So Young, Healy, Jane, Richards, Kristy L., Fedoriw, Yuri, Bernal-Mizrachi, Leon, Koff, Jean L., Staton, Ashley D., Flowers, Christopher R., Paltiel, Ora, Goldschmidt, Neta, Calaminici, Maria, Clear, Andrew, Gribben, John, Nguyen, Evelyn, Czader, Magdalena B., Ondrejka, Sarah L., Collie, Angela, Hsi, Eric D., Tse, Eric, Au-Yeung, Rex K.H., Kwong, Yok-Lam, Srivastava, Gopesh, Choi, William W.L., Evens, Andrew M., Pilichowska, Monika, Sengar, Manju, Reddy, Nishitha, Li, Shaoying, Chadburn, Amy, Gordon, Leo I., Jaffe, Elaine S., Levy, Shawn, Rempel, Rachel, Tzeng, Tiffany, Happ, Lanie E., Dave, Tushar, Rajagopalan, Deepthi, Datta, Jyotishka, Dunson, David B., Dave, Sandeep S.

“…Diffuse large B cell lymphoma (DLBCL) is the most common form of blood cancer and is characterized by a striking degree of genetic and clinical heterogeneity…”
Get full text

Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer by Prahm, Kira Philipsen, Høgdall, Claus, Karlsen, Mona Aarenstrup, Christensen, Ib Jarle, Novotny, Guy Wayne, Høgdall, Estrid

“…Ovarian cancer is the leading cause of death by gynecologic cancers in the Western world. The aim of the study was to identify microRNAs (miRNAs) associated…”
Get full text

Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab by Boisen, Mogens K, Dehlendorff, Christian, Linnemann, Dorte, Nielsen, Boye S, Larsen, Jim S, Osterlind, Kell, Nielsen, Svend E, Tarpgaard, Line S, Qvortrup, Camilla, Pfeiffer, Per, Holländer, Niels H, Keldsen, Nina, Hansen, Torben F, Jensen, Brita B, Høgdall, Estrid V S, Jensen, Benny V, Johansen, Julia S

“…We tested the hypothesis that expression of microRNAs (miRNAs) in cancer tissue can predict effectiveness of bevacizumab added to capecitabine and oxaliplatin…”
Get full text

Cancer antigen 125 and prognosis by Høgdall, Estrid

“…This review addresses recently reported progress in cancer antigen 125 as a prognostic marker in patients with ovarian cancer. Serum cancer antigen 125 levels…”
Get full text

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population by Song, Honglin, Dicks, Ed, Ramus, Susan J, Tyrer, Jonathan P, Intermaggio, Maria P, Hayward, Jane, Edlund, Christopher K, Conti, David, Harrington, Patricia, Fraser, Lindsay, Philpott, Susan, Anderson, Christopher, Rosenthal, Adam, Gentry-Maharaj, Aleksandra, Bowtell, David D, Alsop, Kathryn, Cicek, Mine S, Cunningham, Julie M, Fridley, Brooke L, Alsop, Jennifer, Jimenez-Linan, Mercedes, Høgdall, Estrid, Høgdall, Claus K, Jensen, Allan, Kjaer, Susanne Krüger, Lubiński, Jan, Huzarski, Tomasz, Jakubowska, Anna, Gronwald, Jacek, Poblete, Samantha, Lele, Shashi, Sucheston-Campbell, Lara, Moysich, Kirsten B, Odunsi, Kunle, Goode, Ellen L, Menon, Usha, Jacobs, Ian J, Gayther, Simon A, Pharoah, Paul D P

“…The aim of this study was to estimate the contribution of deleterious mutations in the RAD51B, RAD51C, and RAD51D genes to invasive epithelial ovarian cancer…”
Get full text

Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status by Jensen, Benny Vittrup, Schou, Jakob V., Yilmaz, Mette, Johannesen, Helle H., Skougaard, Kristin, Linnemann, Dorte, Hogdall, Estrid V., Larsen, Finn O., Johansen, Julia S., Pfeiffer, Per, Nielsen, Dorte L.

“…Metastatic colorectal cancer (mCRC) is treated with cetuximab 250 mg/m2 administered weekly over 1 hour or biweekly (q2w) over 3.5 hours when combined with…”
Get full text

Evaluation of the Oncomine Comprehensive Assay Plus NGS Panel and the OncoScan CNV Assay for Homologous Recombination Deficiency Detection by Schejbel, Lone, Poulsen, Tim Svenstrup, Vestergaard, Lau Kræsing, Christensen, Ib Jarle, Høgdall, Estrid

Get full text

miR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-KRAS mutant patients treated with 3rd line cetuximab and irinotecan by Schou, Jakob V, Rossi, Simona, Jensen, Benny V, Nielsen, Dorte L, Pfeiffer, Per, Høgdall, Estrid, Yilmaz, Mette, Tejpar, Sabine, Delorenzi, Mauro, Kruhøffer, Mogens, Johansen, Julia S

“…MicroRNAs (miRNAs) have important regulatory functions in cellular processes and have shown promising potential as prognostic markers for disease outcome in…”
Get full text

Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas by Breinholt, Marie Fredslund, Schejbel, Lone, Gang, Anne Ortved, Nielsen, Torsten Holm, Pedersen, Lars Møller, Høgdall, Estrid, Nørgaard, Peter

“…Integration of molecular characterization of lymphomas in clinical diagnostics may improve subclassification and risk-stratification, and we implemented a next…”
Get full text

A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies by Jensen, Steffen Grann, Epistolio, Samantha, Madsen, Cesilie Lind, Kyneb, Majbritt Hauge, Riva, Alice, Paganotti, Alessia, Barizzi, Jessica, Petersen, Rasmus Koefoed, Børgesen, Michael, Molinari, Francesca, Boldorini, Renzo, Lorenzen, Jan, Sørensen, Erik, Christensen, Ulf Bech, Høgdall, Estrid, Frattini, Milo

“…A major perspective for the use of circulating tumor DNA (ctDNA) in the clinical setting of non-small cell lung cancer (NSCLC) is expected as predictive factor…”
Get full text

Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers by Pedersen, Mette Ølgod, Gang, Anne Ortved, Brown, Peter, Pedersen, Michael, Knudsen, Helle, Nielsen, Signe Ledou, Poulsen, Tim, Wirenfeldt Klausen, Tobias, Høgdall, Estrid, Nørgaard, Peter

“…Double expression of MYC and BCL2 proteins (DE) and double-hit MYC+BCL2/BCL6 translocations (DH) were established as important biomarkers in patients with…”
Get full text

Nivolumab With or Without Ipilimumab Combined with Stereotactic Body Radiotherapy in patients with Metastatic Biliary Tract Cancer: A Randomized Phase 2 Study by Markussen, Alice, Johansen, Julia S, Larsen, Finn O, Theile, Susann, Hasselby, Jane P, Willemoe, Gro L, Lorentzen, Torben, Madsen, Kasper, Høgdall, Estrid, Poulsen, Tim S, Wilken, Eva E, Geertsen, Poul, Behrens, Claus P, Svane, Inge M, Nielsen, Dorte, Chen, Inna M

“…Evaluate the clinical benefits of nivolumab with/without ipilimumab combined with stereotactic body radiotherapy (SBRT) in patients with pretreated metastatic…”
Get full text

The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period by KJAER, Susanne, HØGDALL, Estrid, FREDERIKSEN, Kirsten, MUNK, Christian, VAN DEN BRULE, Adriaan, SVARE, Edith, MEIJER, Chris, LORINCZ, Attilla, IFTNER, Thomas

“…In spite of the success of cervical cytology as a cancer-screening tool, it has important limitations, and human papillomavirus (HPV) testing may be valuable…”
Get full text